MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-05-2026
Masimo Corporation DIO Ratio 2011-2026 | MASI
Annual DIO Ratio Masimo Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 168 | 183 | 134 | 98.4 | - | 137 | 122 | 126 | 103 | 130 | - | 110 | 104 | 137 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 183 | 98.4 | 129 |
Quarterly DIO Ratio Masimo Corporation
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 233 | - | 213 | 205 | 197 | - | - | - | 361 | - | - | - | - | - | 98.5 | 197 | - | 180 | 172 | 96.5 | - | 166 | 113 | 126 | - | 145 | 140 | 120 | - | 124 | 124 | 123 | - | 121 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 361 | 96.5 | 163 |
DIO Ratio of other stocks in the Medical instruments industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
213 | $ 59.8 | -0.96 % | $ 11.9 B |  USA |
 |
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
265 | - | - | $ 1.75 B | USA |
 |
iRhythm Technologies
IRTC
|
29.6 | $ 115.3 | 1.0 % | $ 3.69 B | USA |
 |
ICU Medical
ICUI
|
155 | $ 119.07 | -3.19 % | $ 2.93 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
66.1 | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
177 | $ 422.83 | -1.22 % | $ 151 B | USA |
 |
Repro Med Systems
KRMD
|
76.2 | $ 3.96 | -0.63 % | $ 183 M | USA |
 |
Alcon
ALC
|
126 | $ 63.71 | -0.48 % | $ 40.4 B |  Schweiz |
 |
LeMaitre Vascular
LMAT
|
338 | $ 97.24 | -2.27 % | $ 2.2 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
105 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
106 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
0.917 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
91.4 | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
288 | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
78.3 | $ 23.53 | -1.34 % | $ 3.95 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
105 | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
142 | $ 6.0 | -6.69 % | $ 50.9 K | USA |
 |
Haemonetics Corporation
HAE
|
204 | $ 57.22 | 0.18 % | $ 2.88 B | USA |
 |
Isoray
ISR
|
159 | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
193 | $ 142.59 | 0.31 % | $ 6.91 B | USA |
 |
STAAR Surgical Company
STAA
|
164 | $ 32.51 | 1.56 % | $ 1.61 B | USA |
 |
STERIS plc
STE
|
75 | $ 212.38 | -1.67 % | $ 20.9 B | USA |
 |
Teleflex Incorporated
TFX
|
149 | $ 129.68 | -0.46 % | $ 5.79 B | USA |
 |
InfuSystem Holdings
INFU
|
34.5 | $ 8.68 | 0.52 % | $ 179 M | USA |
 |
Milestone Scientific
MLSS
|
533 | $ 0.33 | -3.06 % | $ 27.1 M | USA |
 |
Merit Medical Systems
MMSI
|
150 | $ 61.52 | -1.66 % | $ 3.64 B | USA |
 |
Utah Medical Products
UTMD
|
185 | $ 63.27 | -0.68 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
76 | $ 304.2 | 1.33 % | $ 22 B | USA |
 |
Pulse Biosciences
PLSE
|
46 | $ 24.37 | -10.07 % | $ 1.64 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
120 | $ 9.96 | -4.37 % | $ 1.99 B | USA |
 |
Retractable Technologies
RVP
|
174 | $ 0.67 | -3.48 % | $ 20.1 M | USA |
 |
Pro-Dex
PDEX
|
145 | $ 60.46 | 3.09 % | $ 199 M | USA |
 |
Predictive Oncology
POAI
|
1.12 K | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
317 | $ 20.35 | -3.37 % | $ 972 M | USA |
 |
Stereotaxis
STXS
|
213 | $ 1.89 | -3.08 % | $ 172 M | USA |
 |
Baxter International
BAX
|
99.3 | $ 17.29 | -2.76 % | $ 8.87 B | USA |
 |
ResMed
RMD
|
141 | $ 202.34 | -0.06 % | $ 29.6 B | USA |
 |
AtriCure
ATRC
|
210 | $ 27.89 | -0.92 % | $ 1.33 B | USA |
 |
Harvard Bioscience
HBIO
|
219 | $ 5.27 | -4.53 % | $ 234 M | USA |
 |
NeuroMetrix
NURO
|
392 | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
166 | $ 10.87 | -1.45 % | $ 444 M | USA |
 |
Becton, Dickinson and Company
BDX
|
119 | $ 142.87 | -1.11 % | $ 41.1 B | USA |
 |
Nephros
NEPH
|
149 | $ 3.18 | -4.79 % | $ 33.7 M | USA |
 |
OraSure Technologies
OSUR
|
178 | $ 3.07 | 3.9 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
162 | $ 104.92 | 1.49 % | $ 5.9 M | USA |